Extracellular vesicles derived from nasopharyngeal carcinoma induce the emergence of mature regulatory dendritic cells using a galectin‐9 dependent mechanism
Journal of Extracellular Vesicles · 2023-12 · 12 (12)
DOI: 10.1002/jev2.12390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 20.12.2023. Verfasst von Anthony Lefebvre und 12 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Lille, Inserm, CHU Lille U1189 - ONCO-THAI - Assisted Laser Therapy and Immunotherapy for Oncology, Lille, France. Hauptthemen laut MEDLINE: Extracellular Vesicles, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canceropole Nord Ouest.
Abstract (Originalsprache)
Nasopharyngeal carcinoma‐derived small extracellular vesicles (NPCSEVs) have an immunosuppressive impact on the tumour microenvironment. In this study, we investigated their influence on the generation of tolerogenic dendritic cells and the potential involvement of the galectin‐9 (Gal9) they carry in this process. We analysed the phenotype and immunosuppressive properties of NPCSEVs and explored the ability of DCs exposed to NPCSEVs (NPCSEV‐DCs) to regulate T cell proliferation. To assess their impact at the pathophysiological level, we performed real‐time fluorescent chemoattraction assays. Finally, we analysed phenotype and immunosuppressive functions of NPCSEV‐DCs using a proprietary anti‐Gal9 neutralising antibody to assess the role of Gal9 in this effect. We described that NPCSEV‐DCs were able to inhibit T cell proliferation despite their mature phenotype. These mature regulatory DCs (mregDCs) have a specific oxidative metabolism and secrete high levels of IL‐4. Chemoattraction assays revealed that NPCSEVs could preferentially recruit NPCSEV‐DCs. Finally, and very interestingly, the reduction of the immunosuppressive function of NPCSEV‐DCs using an anti‐Gal9 antibody clearly suggested an important role for vesicular Gal9 in the induction of mregDCs. These results revealed for the first time that NPCSEVs promote the emergence of mregDCs using a galectin‐9 dependent mechanism and open new perspectives for antitumour immunotherapy targeting NPCSEVs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Univ. Lille, Inserm, CHU Lille U1189 - ONCO-THAI - Assisted Laser Therapy and Immunotherapy for Oncology, Lille, France.
- Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France.
- CHU Lille, Laboratoire de Toxicologie, Lille, France.
- Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, Lille, France.
ORCID-Profile: Olivier Moralès
Förderung
- Canceropole Nord Ouest
Zitieren
APA
Lefebvre, A., Trioën, C., Renaud, S., Laine, W., Hennart, B., Bouchez, C., Leroux, B., Allorge, D., Kluza, J., Werkmeister, E., Grolez, G. P., Delhem, N., & Moralès, O. (2023). Extracellular vesicles derived from nasopharyngeal carcinoma induce the emergence of mature regulatory dendritic cells using a galectin‐9 dependent mechanism. Journal of Extracellular Vesicles, 12(12). https://doi.org/10.1002/jev2.12390
Vancouver
Lefebvre A, Trioën C, Renaud S, Laine W, Hennart B, Bouchez C, et al. Extracellular vesicles derived from nasopharyngeal carcinoma induce the emergence of mature regulatory dendritic cells using a galectin‐9 dependent mechanism. Journal of Extracellular Vesicles. 2023;12(12). doi:10.1002/jev2.12390
BibTeX
@article{Lefebvre2023,
author = {Lefebvre, Anthony and Trioën, Camille and Renaud, Sarah and Laine, William and Hennart, Benjamin and Bouchez, Clément and Leroux, Bertrand and Allorge, Delphine and Kluza, Jérôme and Werkmeister, Elisabeth and Grolez, Guillaume Paul and Delhem, Nadira and Moralès, Olivier},
title = {Extracellular vesicles derived from nasopharyngeal carcinoma induce the emergence of mature regulatory dendritic cells using a galectin‐9 dependent mechanism},
journal = {Journal of Extracellular Vesicles},
year = {2023},
volume = {12},
number = {12},
doi = {10.1002/jev2.12390}
}
EUVIMED